Home Harmonization in hemolysis detection and prevention. A working group of the Catalonian Health Institute (ICS) experience
Article
Licensed
Unlicensed Requires Authentication

Harmonization in hemolysis detection and prevention. A working group of the Catalonian Health Institute (ICS) experience

  • Pilar Fernandez , María Antonia Llopis , Carmen Perich EMAIL logo , Maria Jesús Alsina , Virtudes Alvarez , Carmen Biosca , Gloria Busquets , Maria Vicenta Domenech , Rubén Gómez , Isabel Llovet , Joana Minchinela , Rosa Pastor , Rosa Ruiz , Ester Tarrés , Mercè Ibarz , Margarita Simón and Mercè Montesinos
Published/Copyright: June 4, 2014

Abstract

Background: Hemolysis is the main cause of non-quality samples in clinical laboratories, producing the highest percentage of rejections in the external assurance programs of preanalytical quality. The objective was to: 1) study the agreement between the detection methods and quantification of hemolysis; 2) establish comparable hemolysis interference limits for a series of tests and analytical methods; and 3) study the preanalytical variables which most influence hemolysis production.

Methods: Different hemoglobin concentration standards were prepared using the reference method. Agreement was studied between automated methods [hemolytic indexes (HI)] and reference method, as well as the interference according to hemolysis degree in various biochemical tests was measured. Preanalytical variables which could influence hemolysis production were studied: type of extraction, type of tubes, transport time, temperature and centrifugation conditions.

Results: Good agreement was obtained between hemoglobin concentrations measured using the reference method and HI, for the most of studied analyzers, particularly those giving quantitative HI. The hemolysis interference cut-off points obtained for the majority of tests studied (except LDH, K) are dependent on the method/analyzer utilized. Furthermore, discrepancies have been observed between interference limits recommended by the manufacturer. The preanalytical variables which produce a lower percentage of hemolysis rejections were: centrifugation at the extraction site, the use of lower volume tubes and a transport time under 15 min at room temperature.

Conclusions: The setting of interference limits (cut-off) for each used test/method, and the study of preanalytical variability will assist to the results harmonization for this quality indicator.


Corresponding author: Carmen Perich, Laboratori Clínic Bon Pastor, Mollerusa s/n, Barcelona 08030, Spain, E-mail:

References

1. Alsina MJ, Alvarez V, Barba N, Bullich S, Cortes M, Escoda I, et al. Preanalytical quality control program – an overview of results (2001–2005 summary). Clin Chem Lab Med 2008:46;849–54.10.1515/CCLM.2008.168Search in Google Scholar PubMed

2. Dale JC, Novis DA. Outpatient phlebotomy success and reason for specimen rejection. A Q-Probes Study. Arch Pathol Lab Med 2002;126:416–9.Search in Google Scholar

3. Gómez R, Alsina MJ, Alvarez V, Nuria B, Cortés M, Lopis MA, et al. Hemólisis en las muestras para diagnóstico. Rev Lab Clin 2009;2:185–95.10.1016/j.labcli.2009.08.002Search in Google Scholar

4. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med 2008;46;764–72.10.1515/CCLM.2008.170Search in Google Scholar PubMed

5. Burns ER, Yoshikawa N. Hemolysis in serum samples drawn by emergency department personnel versus laboratory phlebotomists. Lab Med 2002;33:378–80.10.1309/PGM4-4F8L-2P1M-LKPBSearch in Google Scholar

6. Cox SR, Dages JH, Jarjoura D, Hazelett S. Blood samples drawn from IV catheters have less hemolysis when 5-mL (vs. 10-mL) collection tubes are used. J Emerg Nurs 2004;30:529–33.10.1016/j.jen.2004.10.004Search in Google Scholar PubMed

7. Alsina MJ, Alvarez C, Biosca C, Domenech MV, Ibarz M, Minchinela J, et al. Quality indicators and specifications for key processes. Clin Chem Lab Med 2007;45:672–7.Search in Google Scholar

8. Ricós C, Biosca C, Ibarz M, Minchinela J, Llopis MA, Perich C. Quality indicators and specifications for strategic and support processes in laboratory medicine. Clin Chem Lab Med 2008;46:1189–94.10.1515/CCLM.2008.225Search in Google Scholar PubMed

9. Ruiz R, Llopis MA, Biosca C, Trujillo G, Llovet MI, Tarrés E. Indicators and quality specifications for strategic and support processes related to the clinical laboratory: four years’ experience. Clin Chem Lab Med 2010;48:1015–9.10.1515/CCLM.2010.229Search in Google Scholar PubMed

10. Llopis MA, Trujillo G, Llovet MI, Tarrés E, Ibarz M, Biosca C, et al. Quality indicators and specifications for key analytical-extranalytical processes in the clinical laboratory. Five years’ experience using six-sigma concept. Clin Chem Lab Med 2011;49:463–70.10.1515/CCLM.2011.067Search in Google Scholar PubMed

11. Kenny D, Fraser CG, Hyltoft P, Kallner A. Strategies to set global analytical quality specifications in laboratory medicine – Consensus agreement. Scand J Clin Lab Invest 1999;59:585.Search in Google Scholar

12. National Committee for Clinical Laboratory Standards. Reference and selected procedures for the quantitative determination of haemoglobin in blood: approved standard, 3rd ed. NCCLS document H15-A3. Wayne, PA: NCCLS, 2000.Search in Google Scholar

13. Ricós C, Alvarez V, Cava F, García-Lario JV, Hernández A, Jiménez CV, et al. Current data bases on biological variation pros, cons and progress. Scand J Clin Lab Invest 1999;59: 491–500.10.1080/00365519950185229Search in Google Scholar PubMed

14. Lippi G, Salvagno GL, Montagnana M, Brocco G, Guidi GC. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med 2006;44:311–6.10.1515/CCLM.2006.054Search in Google Scholar PubMed

15. Fleiss JL. Statistical methods for rates and proportions, 2nd ed. John Wiley; New York, 1981.Search in Google Scholar

16. Clinical and Laboratory Standards Institute. Protocols for determination of limits of detection and limits of quantitation, approved guideline. CLSI document EP17. Wayne, PA: CLSI, 2004.Search in Google Scholar

17. Glick M, Ryder K, Gliks S, Woods J. Unreliable visual estimation of the incident and amount of turbidity hemolysis, and icterus in serum from hospitalized patients. Clin Chem 1989;35:837–9.10.1093/clinchem/35.5.837Search in Google Scholar

18. Simundic AM, Nikolac N, Ivankovic V, Ferenec-Ruzic D, Magdic B, Kvaternik M, et al. Comparison of visual versus automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye? Clin Chem Lab Med 2009;47:1361–5.10.1515/CCLM.2009.306Search in Google Scholar PubMed

19. Lippi G, Salvagno GL, Blanckaert N, Giavarina D, Green S, Kitchen S, et al. Multicenter evaluation of the hemolysis index in automated clinical chemistry systems. Clin Chem Lab Med 2009;47:34–9.10.1515/CCLM.2009.218Search in Google Scholar PubMed

20. Steen G, Vermeer HJ, Naus AJ, Goevaerts B, Agricola PT, Schoenmarkers CH. Multicenter evaluation of the interference of haemoglobin, bilirubin and lipids on Synchron LX-20 assays. Clin Chem Lab Med 2006;44:413–9.10.1515/CCLM.2006.067Search in Google Scholar PubMed

21. Lippi G, Avanzini P, Campioli D, Da Rin G, Dipalo M, Aloe R, et al. Systematical assessment of serum indices does not impair efficiency of clinical chemistry testing: a multicenter study. Clin Biochem 2013;46:1281–4.10.1016/j.clinbiochem.2013.06.007Search in Google Scholar PubMed

22. Dolci A, Panteghini M. Harmonization of automated haemolysis index assessment and use: is it possible? Clin Chim Acta 2013. doi: 10.1016/j.cca.2013.10.012. [Epub ahead of print 24 Oct 2014].10.1016/j.cca.2013.10.012Search in Google Scholar PubMed

23. Fraser CG. Biological variation: from principles to practice. Washington, DC: AACC Press, 2001.Search in Google Scholar

24. Bais R, Armbruster D, Jansen RT, Klee G, Panteghini M, Passarelli J, et al. The IFCC working group on allowable errors for traceable results. Defining acceptable limits for the metrological traceability of specific measurands. Clin Chem Lab Med 2013;51:973–9.10.1515/cclm-2013-0122Search in Google Scholar PubMed

25. CLSI document C56-A. Haemolysis, icterus, and lipemia/turbidity indices as indicators of interference in clinical laboratory analysis; approved guideline. Wayne, PA: CLSI, 2012.Search in Google Scholar

26. Boyanton Jr. BL, Blick KE. Stability studies of twenty-four analytes in human plasma and serum. Clin Chem 2002;48:2242–7.10.1093/clinchem/48.12.2242Search in Google Scholar

27. Lippi G, Jeffrey JC, Church S, Dazzi P, Fontana R, Giavarina D, et al. Preanalytical quality improvement: from dream to reality. Clin Chem Med Lab 2011;49:1113–26.10.1515/CCLM.2011.600Search in Google Scholar PubMed

Received: 2013-10-31
Accepted: 2014-4-25
Published Online: 2014-6-4
Published in Print: 2014-11-19

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. From symptoms to biomarkers: a change of paradigm
  4. Reviews
  5. Biochemical markers in early diagnosis and management of systemic amyloidoses
  6. The accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: a meta-analysis
  7. Genetics and Molecular Diagnostics
  8. Selection of an optimal method for co-isolation of circulating DNA and miRNA from the plasma of pregnant women
  9. General Clinical Chemistry and Laboratory Medicine
  10. Harmonisation of seven common enzyme results through EQA
  11. Harmonization in hemolysis detection and prevention. A working group of the Catalonian Health Institute (ICS) experience
  12. Adopting European Network for Health Technology Assessments (EunetHTA) core model for diagnostic technologies for improving the accuracy and appropriateness of blood gas analyzers’ assessment
  13. Impact of assay design on test performance: lessons learned from 25-hydroxyvitamin D
  14. Anti-ruthenium antibodies mimic macro-TSH in electrochemiluminescent immunoassay
  15. The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients
  16. Quantification of polyclonal free light chains in clinical samples using a single turbidimetric immunoassay
  17. Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate
  18. Reference Values and Biological Variations
  19. The importance of individual biology in the clinical use of serum biomarkers for ovarian cancer
  20. The quality of diagnostic testing may be impaired during shipment of lithium-heparin gel tubes
  21. Cancer Diagnostics
  22. Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer
  23. Intestinal permeability in patients with metastatic colon cancer treated with patupilone
  24. Cardiovascular Diseases
  25. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay
  26. Infectious Diseases
  27. Early indicators of severity and construction of a risk model for prognosis based upon laboratory parameters in patients with hemorrhagic fever with renal syndrome
  28. Corrigendum
  29. Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation
  30. Letters to the Editor
  31. The future of the laboratory information system – what are the requirements for a powerful system for a laboratory data management?
  32. Hypernatraemia in disguise
  33. Interference of therapeutic monoclonal immunoglobulins in the investigation of M-proteins
  34. The impact of exercise on the variation of serum free light chains
  35. Response to Jacobs: N Latex FLC serum free light-chain assays in patients with renal impairment
  36. Reply to Berlanga et al. (DOI 10.1515/cclm-2014-0420)
  37. Mean platelet volume in patients with non-alcoholic fatty liver disease: is mean platelet volume ready as a surrogate marker?
  38. False-positive D-dimer result in a latex-enhanced immunoassay caused by interfering human anti-mouse antibodies
  39. D-Dimer in normal pregnancy: determination of reference values for three commercially available assays
  40. Paraoxonase 2 sequence variation (c.311 C>G) is associated with a modest decrease in circulating LDL size in children and adolescents
  41. The effect of volume of hydrochloric acid preservation on 24-hour urinary catecholamine test
  42. Congress Abstracts
  43. Congress of Clinical Chemistry and Laboratory Medicine
  44. The 3rd EFLM-UEMS Congress
  45. 46th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
Downloaded on 27.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2013-0935/html
Scroll to top button